whilst no major change on PXS's schedule, there is somehow an indication that Synairgen may delay the pre-clinical for Loxl2. It was originally scheduled this calendar year on 2016, but now seems will push to 2017.
Synairgen is having some headwind as their 1 of the 2 drugs is trashed (phase 2 terminated).
